Pages with the most revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #151 to #200.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Intracranial hematomas (52 revisions)
- Crystals in body fluids (51 revisions)
- Osteoarthritis (50 revisions)
- Intraoperative consultation (50 revisions)
- Gastrointestinal cytopathology (50 revisions)
- Pheochromocytoma (49 revisions)
- Tuberous sclerosis (49 revisions)
- Ampulla of Vater (49 revisions)
- TFE3-rearranged renal cell carcinoma (48 revisions)
- Neuroendocrine neoplasms (48 revisions)
- ELOC-mutated renal cell carcinoma (48 revisions)
- L4E rule 1-3 (2014) (47 revisions)
- Congenital heart disease (47 revisions)
- Chromophobe renal cell carcinoma (47 revisions)
- Granular cell tumour (46 revisions)
- Rhabdomyosarcoma (45 revisions)
- Hypertension (45 revisions)
- Pulmonary embolism (45 revisions)
- Astrocytoma (45 revisions)
- Urine cytopathology (45 revisions)
- Gunshot wounds (45 revisions)
- Desmoid-type fibromatosis (44 revisions)
- TFEB-rearranged renal cell carcinoma (44 revisions)
- Breast cytopathology (44 revisions)
- Chromosomal translocations (44 revisions)
- Seminoma (44 revisions)
- Craniopharyngioma (43 revisions)
- Giant cell arteritis (43 revisions)
- Renal mucinous tubular and spindle cell carcinoma (43 revisions)
- Joints (43 revisions)
- Familial adenomatous polyposis (43 revisions)
- Diverticular disease (43 revisions)
- Mucinous carcinoma (42 revisions)
- Sarcoidosis (42 revisions)
- Small cell carcinoma of the lung (42 revisions)
- Level 4 equivalent of 2014 (42 revisions)
- Basal cell carcinoma (42 revisions)
- Secretory carcinoma of the salivary gland (42 revisions)
- SMARCB1-deficient renal medullary carcinoma (42 revisions)
- Lymph node metastasis (42 revisions)
- OP:Sandbox3 (42 revisions)
- P16 (42 revisions)
- Renal tumours with eosinophilic cytoplasm (41 revisions)
- Leiomyoma (41 revisions)
- Small cell carcinoma (41 revisions)
- Programmed death-ligand 1 (41 revisions)
- Ependymoma (41 revisions)
- Signet ring cell carcinoma (40 revisions)
- Cystic kidney diseases (40 revisions)
- Nephrogenic adenoma (40 revisions)